Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy

Jeffrey D Lebensburger1, Inmaculada Aban2, Brandi Pernell1

  • 1Division of Pediatric Hematology Oncology, University of Alabama at Birmingham, Birmingham, Alabama.

Insights

Hyperfiltration, an early sign in pediatric sickle cell anemia (SCA), precedes kidney damage like albuminuria. Early interventions targeting kidney function may prevent disease progression in these children.

Area of Science:

  • Nephrology
  • Pediatrics
  • Hematology

Background:

  • Hyperfiltration is a known precursor to albuminuria in diabetes.
  • Pediatric sickle cell anemia (SCA) patients exhibit high rates of hyperfiltration and albuminuria early in life.

Purpose of the Study:

  • To investigate if hyperfiltration precedes albuminuria in a longitudinal cohort of pediatric SCA patients.
  • To analyze the temporal relationship between hyperfiltration and the onset of persistent albuminuria.

Main Methods:

  • A cohort of 91 pediatric SCA patients (5-21 years) with baseline cystatin C measurements (4-10 years) was analyzed.
  • Hyperfiltration was defined as mean eGFR >180 mL/min/1.73m²; persistent albuminuria as ACR >30 mg/g on two occasions.
  • Kaplan-Meier curves and log-rank tests assessed the association between early hyperfiltration and time to persistent albuminuria.

Main Results:

  • Persistent albuminuria developed earlier and more frequently in children with early hyperfiltration (log-rank, P=.004).
  • Children who developed albuminuria showed a significant eGFR increase during childhood (P=.003), unlike those without albuminuria (P=.26).
  • Higher hemoglobin levels correlated with a reduced hazard ratio for developing persistent proteinuria (HR=0.56, P=.07).

Conclusions:

  • Hyperfiltration is a significant predictor that precedes persistent proteinuria in pediatric SCA.
  • Interventions aimed at reducing estimated glomerular filtration rate (eGFR) in early childhood are recommended for pediatric SCA patients.
Abstract

Related Concept Videos

Erikson's Theory on Socioemotional Development during Childhood01:28

Erikson's Theory on Socioemotional Development during Childhood

Erik Erikson, a stage theorist, adapted Freud's theory to emphasize social factors in personality development throughout life, a concept known as psychosocial development. Unlike Freud, who focused on early childhood, Erikson believed that personality evolves across eight life stages, each marked by a specific challenge or "crisis." Successful resolution of each stage fosters competence, while failure may lead to feelings of inadequacy.
The first four of Erikson's eight...
1.0K
Piaget's Theory of Cognitive Development from Childhood into Adulthood01:25

Piaget's Theory of Cognitive Development from Childhood into Adulthood

Jean Piaget's theory of cognitive development emphasizes the role of thinking in a child's learning process, suggesting that children are naturally curious about their environment. His approach to development is discontinuous, proposing that cognitive abilities progress through distinct stages, each with unique characteristics. Central to Piaget's theory is schemata—mental structures that allow individuals to understand and interpret the world.
Schemata: Building Blocks of Knowledge
1.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
261
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
296